PREVADDUCT
Live / Applied — Third extension granted (statement of use) (as of 24 Mar 2026)
What this means for you
Not registered yet, but its 10 Nov 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98265442
- Mark type
- Stylized text
- Filed
- 10 Nov 2023
- Published for opposition
- 30 Jul 2024
- Attorney of record
- Emily Harris
Goods and services
- Class 005 — Pharmaceuticals: Anti-inflammatory preparations; Chemical preparations for pharmaceutical or medical purposes, namely, for oxidative damage, isoketal activity and chronic inflammation; Chemical preparations for pharmaceutical or medical purposes, namely, for diseases resulting from oxidative damage, isoketal activity or inflammation; Dietary and nutritional supplements; Digestives for pharmaceutical purposes; Food supplements, namely, anti-oxidants; Medical preparations for the treatment of oxidative damage, isoketal activity and chronic inflammation; Medicinal preparations for inflammation; Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents for epidermis; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical preparation for skin care; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for the prevention of inflammation; Pharmaceutical preparations for the prevention of inflammatory diseases; Pharmaceutical preparations for the prevention of oxidative damage; Pharmaceutical preparations for the prevention of chronic inflammation; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of hormonal disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations for the treatment of chronic inflammation; Pharmaceutical preparations for the treatment of oxidative damage; Pharmaceutical preparations for the treatment of isoketal activity diseases and conditions; Pharmaceutical preparations for the treatment of musculoskeletal, cardiovascular, cardiopulmonary, and immune system related diseases and disorders; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating asthma; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for inflammation; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, antivirals; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products and preparations for pregnancy blemishes; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for treating respiratory diseases; Preparation for the relief of pain
Owner
- Adduct Pharmaceutical, Inc., Ames, IA, US
- Adduct Pharmaceutical, Inc., Ames, IA, US
Prosecution history
- 25 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Mar 2026 — SOU EXTENSION 3 GRANTED
- 24 Mar 2026 — SOU EXTENSION 3 FILED
- 24 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 24 Mar 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 24 Mar 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 24 Mar 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 24 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Dec 2025 — SOU EXTENSION 2 GRANTED
- 23 Sept 2025 — SOU EXTENSION 2 FILED
- 23 Dec 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 21 Oct 2025 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 21 Oct 2025 — NOTICE OF REVIVAL - E-MAILED
- 21 Oct 2025 — PETITION TO REVIVE-GRANTED
- 21 Oct 2025 — TEAS PETITION TO REVIVE RECEIVED